ZTOX Insights

SURYAROSNI

SURYAROSNI

Jun 4, 2026 · 1 min read

Market Updates Corporate announcement

Surya Roshni Files Large Corporate Disclosure, Reports Zero Debt

Surya Roshni Ltd has filed its initial Large Corporate disclosure with BSE, revealing zero outstanding borrowings and an AA credit rating assigned by CARE Ratings Limited.

Read article

SUBEXLTD

SUBEXLTD

Jun 4, 2026 · 1 min read

Market Updates Corporate announcement

Subex Faces Stock Exchange Fine Under SEBI Disclosure Rules

Subex Limited (SUBEXLTD) discloses imposition of fine by stock exchanges under SEBI Listing Obligations Regulations, 2015. Details remain limited.

Read article

SAFFRON

SAFFRON

Jun 4, 2026 · 1 min read

Market Updates Corporate announcement

Saffron Industries (SAFFRON) – Exempt from Secretarial Audit for FY 2026

Saffron Industries (BSE: SAFFRON) is exempt from filing an Annual Secretarial Compliance Report for FY 2026, with paid-up capital and networth below SEBI-prescribed limits.

Read article

COSMOFIRST

COSMOFIRST

Jun 4, 2026 · 1 min read

Market Updates Corporate announcement

Cosmo First Posts Q3 Earnings Call Transcript on BSE

Cosmo First has released its Q3 FY25 earnings call transcript through a BSE regulatory filing, giving investors access to the company's earnings discussion and management commentary.

Read article

SUBEXLTD

SUBEXLTD

Jun 4, 2026 · 1 min read

Market Updates Corporate announcement

Subex Discloses SEBI Fine Under Listing Regulations

Subex Ltd has made a regulatory disclosure regarding imposition of a fine by stock exchanges under SEBI Listing Obligations Regulations, 2015.

Read article

ANGELONE

ANGELONE

Jun 4, 2026 · 1 min read

Market Updates BSE filings

Angel One Monthly Report for May 2026 Published on BSE

Angel One has filed its May 2026 monthly business update with BSE. Retail investors tracking ANGELONE stock can access the disclosure filed under SEBI listing requirements.

Read article

GENESYS

GENESYS

Jun 4, 2026 · 1 min read

Market Updates Corporate announcement

Genesys International Fined Rs 8.37 Lakh by BSE, NSE for Regulatory Lapse

Genesys International has been penalised Rs 4,18,900 each by BSE and NSE for failing to comply with SEBI LODR Regulation 17(1), set to impact investor sentiment.

Read article

GENESYS

GENESYS

Jun 4, 2026 · 1 min read

Market Updates Corporate announcement

Genesys International Fined Rs 8.38 Lakh for SEBI Non-Compliance

Genesys International faces a combined fine of Rs 8.38 lakh after BSE and NSE penalised the company for non-compliance with SEBI board composition rules under Regulation 17(1).

Read article

SUDEEPPHRM

SUDEEPPHRM

Jun 4, 2026 · 1 min read

Market Updates Corporate announcement

Sudeep Pharma Announces Transcript Release from Investor Call

Sudeep Pharma Limited has informed the NSE about the availability of a transcript from its recent investor and analyst conference call.

Read article

VSTL

VSTL

Jun 4, 2026 · 1 min read

Market Updates Corporate announcement

Vibhor Steel Tubes Publishes Analyst Meeting Transcript on NSE

Vibhor Steel Tubes Limited has notified the NSE about the availability of a transcript from its recent analysts and institutional investor meeting, offering market participants a window into management perspectives.

Read article

SIPL

SIPL

Jun 4, 2026 · 1 min read

Market Updates Corporate announcement

Shelter Infra Projects Files Q4 FY2026 Results Advertisement

Shelter Infra Projects has disclosed newspaper advertisements for its Q4 FY2026 financial results filed with BSE under SEBI LODR Regulations.

Read article

WINDLAS

WINDLAS

Jun 4, 2026 · 1 min read

Market Updates Earnings conference call

Windlas Biotech Files Transcript of Analyst Call with NSE

Windlas Biotech Limited has filed a transcript of its analyst and institutional investor meeting with NSE, providing market participants with access to discussions from the call.

Read article

WINDLAS

WINDLAS

Jun 4, 2026 · 1 min read

Market Updates Earnings conference call

Windlas Biotech Q4 & FY26 Earnings Conference Call Transcript

Windlas Biotech held its Q4 and FY26 earnings conference call. The transcript has been filed with BSE for investor reference.

Read article